SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001328143-20-000012
Filing Date
2020-02-25
Accepted
2020-02-25 16:03:03
Documents
93
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adms-20191231.htm   iXBRL 10-K 2971722
2 EX-4.4 adms10k2019ex44.htm EX-4.4 17254
3 EX-10.6 adms10k2019ex106.htm EX-10.6 266505
4 EX-10.37 adms10k2019ex1037.htm EX-10.37 28034
5 EX-10.41 adms10k2019ex1041.htm EX-10.41 129002
6 EX-21.1 adms10k2019ex211.htm EX-21.1 3815
7 EX-23.1 adms10k2019ex231.htm EX-23.1 3414
8 EX-31.1 adms10k2019ex311.htm EX-31.1 13746
9 EX-31.2 adms10k2019ex312.htm EX-31.2 13719
10 EX-32.1 adms10k2019ex321.htm EX-32.1 9946
  Complete submission text file 0001328143-20-000012.txt   11744935

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20191231.xsd EX-101.SCH 53697
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20191231_cal.xml EX-101.CAL 107701
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20191231_def.xml EX-101.DEF 327277
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20191231_lab.xml EX-101.LAB 764781
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20191231_pre.xml EX-101.PRE 509036
95 EXTRACTED XBRL INSTANCE DOCUMENT adms-20191231_htm.xml XML 2174396
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36399 | Film No.: 20650560
SIC: 2834 Pharmaceutical Preparations